Serum CA-125 level in patients with gynecologic tumors
Abe, Y.; Ueda, G.; Yamasaki, M.; Inoue, M.; Hiramatsu, K.; Inoue, Y.; Saito, J.; Nishino, T.
Rinsho Byori. Japanese Journal of Clinical Pathology 32(12): 1350-1354
1984
ISSN/ISBN: 0047-1860 PMID: 6597876 Document Number: 231708
Document emailed within 1 workday
Related Documents
Inoue, S.; Shibata, S.; Okumura, A.; Tanaka, T.; Onitsuka, Y.; Yoshimura, T.; Aiko, A.; Ikuta, Y.; Fukuma, K.; Matsuura, K. 1985: UFT concentration in serum and tissues of patients with gynecologic malignant tumors following oral administration Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(3 Part 1): 499-504Michalska, M.; Palatyńska-Ulatowska, A.; Palatyński, A.; Mirowski, M.; Kaplińska, K.; Nawrot-Modranka, J.; Lazarenkow, A. 2011: Influence of antibiotic therapy on the level of selected angiogenic factors in patients with benign gynecologic tumors--preliminary report Die Pharmazie 66(8): 619-622
Kołomecki, K.; Maciaszczyk, P.; Stepień, H.; Cywiński, J.; Cielecka, J.; Stepień, T.; Kuzdak, K. 2006: Evaluation of p53 and soluble Fas ligand (sFasL) serum level concentration as indicators of apoptosis in serum of patients with benign and malignant primary follicular thyroid tumors Endokrynologia Polska 57(4): 320-325
Czeczot, H.; Scibior-Bentkowska, D.; Skrzycki, M.ł; Podsiad, M.łg. 2010: Assessment of lipid peroxidation level in serum of patients with gastrointestinal tract tumors Wiadomosci Lekarskie 63(3): 180-187
Tsutsumi, M.; Suzuki, K.; Shiga, Y.; Ishikawa, S.; Ishikawa, Y. 2002: A low-fat and high soybean protein diet for patients with elevated serum PSA level: alteration of QOL and serum PSA level after the dietary intervention Hinyokika Kiyo. Acta Urologica Japonica 48(4): 207-211
Nakayama, M.; Tanno, Y.; Otsuka, Y.; Takahashi, H.; Ikeda, M.; Katoh, N.; Yokoyama, K.; Yamamoto, H.; Tokutome, G.; Hosoya, T. 2002: Effect of angiotensin II receptor antagonist (losartan) on renal function, serum potassium and blood pressure in patients with advanced renal failure: differences between patients with a serum creatinine (SCr) level higher than 3 mg/dl and those with a lower SCr level Nihon Jinzo Gakkai Shi 44(7): 530-536
Pulay, T.; Keller, G.; Krommer, K.; Kovács, C. 1973: Immunoglobulin level in malignant gynecologic diseases and tumor patients Orvosi Hetilap 114(52): 3146-3148
Wawrzeńczyk, B.; Zaruski, A. 1973: Level of blood serum level of uric acid in tuberculous patients treated with morphazinamide Gruzlica i Choroby Pluc; Tuberculosis et Pneumonologia 41(2): 177-180
Inoue, M.; Shimizu, C.; Sasagawa, T.; Shimizu, H.; Saitoh, J.; Ueda, G.; Tanizawa, O.; Kimura, T.; Kawata, M.; Taniguchi, T. 1987: The clinical value of sialyl SSEA-1 antigen in patients with gynecologic tumors Nihon Sanka Fujinka Gakkai Zasshi 39(12): 2120-2124
Yew, W.W.; Wong, C.F.; Wong, P.C.; Cheung, S.W.; Chan, C.Y.; Cheng, A.F. 1993: Correlation of serum ofloxacin concentration and serum creatinine level in patients on prolonged therapy International Journal of Clinical Pharmacology Research 13(5): 243-245
Andersen, H.J.; Marushak, A. 1985: Preoperative determination of fibrin degradation products (FDP) in the sera of patients with suspected gynecologic tumors Ugeskrift for Laeger 147(21): 1689-1691
Nakajima, Y.; Nakamura, S.; Kimura, S.; Kuramochi, S.; Nakamura, K. 1989: Retroperitoneal germ cell tumors with high level of serum and urine hCG in an adult: a case report Hinyokika Kiyo. Acta Urologica Japonica 35(2): 301-305
Malluche, H.H.; Klempa, I.; Hodgson, M.; Feurle, G.; Koch, K.M. 1974: Serum gastrin level and gastric juice secretion in chronic hemodialysis patients and its effect on them by changing ionized serum calcium Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 690-692
Novikov, V.V.; Mamaeva, M.E.; Aliasova, A.V.; Hazov, M.V.; Kasatova, E.S.; Shumilova, S.V.; Karaulov, A.V. 2015: The Serum Level of Total and Oligomeric Fractions of Soluble Molecules Cd38 under Malignant Tumors of Cervix and Uterine Body Klinicheskaia Laboratornaia Diagnostika 60(5): 32-36
Gralow, I.; von Hornstein, W.; Behling, H. 1991: Pain therapy in patients with gynecologic tumors. Analysis of ambulatory pain management Zentralblatt für Gynakologie 113(23): 1288-1297
Sakurai, Y.; Kodaira, S.; Teramoto, T.; Sugano, K.; Abe, O.; Ohtake, H.; Iri, H. 1989: Clinical evaluation of serum level of NCC-ST-439 as a new tumor marker for colorectal diseases--fluctuation of serum NCC-ST-439 in patients with colorectal cancers before and after surgery Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(9): 3205-3212
Jurancíková, M.; Dyüszüová, M. 1972: Needs and organization of home calls by gynecologic nurses to pregnant women, puerperias and gynecologic patients Ceskoslovenska Gynekologie 37(10): 732-735
Kunze, M.; Büttner, H.H.; Strache, R.R.; Voss, P.; Briese, V.; Schrodt, U. 1988: CEA determination in aspired fluid of cystic ovarian tumors and ovarian cysts and in ascites and serum samples of patients with ovarian tumors Zentralblatt für Gynakologie 110(16): 1006-1012
Cepelja, Z.; Keler-Bacoka, M.; Stojanovski-Bubanj, A.; Grgić, Z.; Popovic, S. 1974: Zinc level in the serum of patients with hemoblastosis Lijecnicki Vjesnik 96(10): 596-598
Kaliuzhnaia, L.D.; Potsybina, V.V.; Stychinskaia, L.P. 1986: Serum trypsin level in patients with atopic dermatitis Vrachebnoe Delo 3: 94-96